Morphic Holding Inc MORF:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
29.23UNCH (UNCH)
Volume
13,126,929
Close
29.23quote price arrow down-3.22 (-9.92%)
Volume
420,858
52 week range
19.34 - 63.08
Loading...
  • Open32.70
  • Day High32.70
  • Day Low28.93
  • Prev Close32.45
  • 52 Week High63.08
  • 52 Week High Date06/12/23
  • 52 Week Low19.34
  • 52 Week Low Date11/01/23

Key Stats

  • Market Cap1.464B
  • Shares Out50.09M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.50
  • YTD % Change1.21

KEY STATS

  • Open32.70
  • Day High32.70
  • Day Low28.93
  • Prev Close32.45
  • 52 Week High63.08
  • 52 Week High Date06/12/23
  • 52 Week Low19.34
  • 52 Week Low Date11/01/23
  • Market Cap1.464B
  • Shares Out50.09M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.50
  • YTD % Change1.21

RATIOS/PROFITABILITY

  • EPS (TTM)-3.49
  • P/E (TTM)-8.37
  • Fwd P/E (NTM)-7.28
  • EBITDA (TTM)-191.969M
  • ROE (TTM)-29.59%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-29,192.90%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Morphic Holding Inc

 

Profile

MORE
Morphic Holding, Inc. is a biopharmaceutical company. The Company is engaged in discovering and developing a pipeline of potentially oral small molecule integrin therapeutics for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. The Company’s Morphic integrin technology platform (MInT Platform) helps to develop product candidates designed to achieve the potency, high selectivity and pharmaceutical...
Gustav Christensen
Independent Chairman of the Board
Praveen Tipirneni M.D.
Chief Executive Officer, Director
Bruce Rogers Ph.D.
President
Marc Schegerin M.D.
Chief Financial Officer, Chief Operating Officer
William DeVaul Esq., J.D.
General Counsel, Secretary
Address
35 GATEHOUSE DRIVE A2
Waltham, MA
02451
United States

Top Peers

SYMBOLLASTCHG%CHG
SYRE
Spyre Therapeutics Inc
37.80UNCHUNCH
AKRO
Akero Therapeutics Inc
19.92-0.81-3.91%
SLNO
Soleno Therapeutics Inc
46.16+0.50+1.10%
KURA
Kura Oncology Inc
22.17-0.81-3.52%
BLTE
Belite Bio Inc
44.95+2.57+6.05%